Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Olema Pharmaceuticals Inc (OLMA)

Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Olema Pharmaceuticals Inc 780 Brannan Street San Francisco CA 94103 USA

www.olema.com Employees: 74 P: 415-651-3316

Description:

Olema Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in discovery, development and commercialization of therapies for women's cancers. The company's product pipeline includes OP-1250, which is in clinical stage. Olema Pharmaceuticals Inc. is based in San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 648,834
Enterprise Value, $K 580,294
Shares Outstanding, K 55,934
Annual Sales, $ 0 K
Annual Net Income, $ -96,660 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -30,380 K
EBIT, $ -121,630 K
EBITDA, $ -121,250 K
60-Month Beta 2.02
% of Insider Shareholders 19.40%
% of Institutional Shareholders 91.78%
Float, K 45,083
% Float 80.60%
Short Volume Ratio 0.50

Growth:

1-Year Return 1.31%
3-Year Return -57.65%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.54 on 08/06/24
Next Earnings Date 11/05/24
Earnings Per Share ttm -2.07
EPS Growth vs. Prev Qtr 3.57%
EPS Growth vs. Prev Year -10.20%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

OLMA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -44.18%
Return-on-Assets % -40.30%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.97
Book Value/Share 4.06
Interest Coverage -4.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar